Irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) can produce similar symptoms, and is difficult to make a differential diagnosis without the use of invasive colonoscopy investigations. Now, however, measurement of faecal calprotectin has proved to distinguish between IBS and IBD.
Studies show that faecal calprotectin concentration is significantly elevated in patients with IBD, while in those suffering from IBS it is not. High concentration correlates well with endoscopy and histological assessment of disease activity.
Alpha Laboratories is experienced in the measurement of human faecal calprotectin and offers the widest range of test formats for this marker. Whether performing the test in primary care, in the gastroenterology clinic or the laboratory, there is a choice of format to suit individual needs.
www.alphalabs.co.uk